Unilife Corporation

Corporate Snapshot

Unilife Corp. ("Unilife" or "the Company") develops and supplies innovative safety medical devices for pharmaceutical and healthcare markets that mandate the use of safety sharps. The Company is progressively launching its patented portfolio of prefilled and clinical syringes under two brands: (1) Unifill, glass-barreled, prefilled safety syringes; and (2) Unitract, a line of plastic-barreled, clinical safety syringes. The distinctive feature of all Unilife syringes is that needle retraction is both automatic and operator controlled within a fully integrated syringe, a combination of safety features that Unilife does not believe is available in any other technology marketed today. The Company's syringes may virtually eliminate the risk of acquiring bloodborne infections, such as HIV or hepatitis C, via needlestick injuries or blood splatter. Unilife holds ISO 13485 certifications with FDA-registered state-of-the-art manufacturing facilities in Pennsylvania. Importantly, sanofi-aventis SA (SNY-NYSE), thought to be the world's largest purchaser of prefilled syringes, is funding up to $38.5 million (pre-sales) for the industrialization and exclusive right to buy the Unifill Syringe in therapeutic areas such as vaccines and antithrombotics.